Tanaya Shree

1.8k total citations · 1 hit paper
27 papers, 1.4k citations indexed

About

Tanaya Shree is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Tanaya Shree has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Pathology and Forensic Medicine and 10 papers in Immunology. Recurrent topics in Tanaya Shree's work include Lymphoma Diagnosis and Treatment (11 papers), CAR-T cell therapy research (9 papers) and Immune Cell Function and Interaction (6 papers). Tanaya Shree is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), CAR-T cell therapy research (9 papers) and Immune Cell Function and Interaction (6 papers). Tanaya Shree collaborates with scholars based in United States, Germany and Canada. Tanaya Shree's co-authors include Johanna A. Joyce, Alfred L. Garfall, Vasilena Gocheva, Bedrick B. Gadea, Tara Berman, Karen E. Hunter, Hao‐Wei Wang, Benelita T. Elie, Katherine M. Bell‐McGuinn and Emily C. Zabor and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Tanaya Shree

25 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion

2010 577 citations Vasilena Gocheva, Hao‐Wei Wang et al. Genes & Development profile →

Peers

Tanaya Shree

ONCOL

IMMUN

PFM

Shilpa Bhatia United States

Elisabetta Rovida Italy

Yasuharu Akasaki Japan

Yan Lan United States

Andrew Deonarine United States

Sandra Pinton Switzerland

Christina Jamieson United States

Satoru Osuka Japan

Fatima Khan United States

Anne Chauchereau France

Shilpa Bhatia United States

Tanaya Shree

706 ×1.1

ONCOL

466 ×0.8

IMMUN

478 ×1.0

137 ×0.4

99 ×1.1

PFM

Citations per year, relative to Tanaya Shree Tanaya Shree (= 1×) peers Shilpa Bhatia

Countries citing papers authored by Tanaya Shree

Since Specialization

Citations

This map shows the geographic impact of Tanaya Shree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanaya Shree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanaya Shree more than expected).

Fields of papers citing papers by Tanaya Shree

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanaya Shree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanaya Shree. The network helps show where Tanaya Shree may publish in the future.

Co-authorship network of co-authors of Tanaya Shree

This figure shows the co-authorship network connecting the top 25 collaborators of Tanaya Shree. A scholar is included among the top collaborators of Tanaya Shree based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanaya Shree. Tanaya Shree is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shree, Tanaya, Debra K. Czerwinski, Sarah Haebe, et al.. (2025). A Phase I Clinical Trial Adding OX40 Agonism to In Situ Therapeutic Cancer Vaccination in Patients with Low-Grade B-cell Lymphoma Highlights Challenges in Translation from Mouse to Human Studies. Clinical Cancer Research. 31(5). 868–880. 1 indexed citations

Grimes, Susan M., Heon Seok Kim, Sharmili Roy, et al.. (2023). Single-cell multi-gene identification of somatic mutations and gene rearrangements in cancer. NAR Cancer. 5(3). zcad034–zcad034. 3 indexed citations

Haebe, Sarah, Debra K. Czerwinski, Anuja Sathe, et al.. (2023). Follicular lymphoma evolves with a surmountable dependency on acquired glycosylation motifs in the B-cell receptor. Blood. 142(26). 2296–2304. 2 indexed citations

Shree, Tanaya, Vishnu Shankar, Debra K. Czerwinski, et al.. (2022). CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity. Blood Cancer Discovery. 3(2). 95–102. 27 indexed citations

Carrot‐Zhang, Jian, Talya L. Dayton, Shila Ghazanfar, et al.. (2022). The 2022 generation. Nature Cancer. 3(12). 1426–1431. 1 indexed citations

Shree, Tanaya, Sarah Haebe, Debra K. Czerwinski, et al.. (2022). Activating Immune Effectors and Dampening Immune Suppressors Generates Successful Therapeutic Cancer Vaccination in Patients with Lymphoma. Blood. 140(Supplement 1). 6450–6451. 1 indexed citations

Shree, Tanaya. (2022). Can B cell‐deficient patients rely on COVID‐19 vaccine‐induced T‐cell immunity?. British Journal of Haematology. 197(6). 659–661. 3 indexed citations

Haebe, Sarah, Tanaya Shree, Anuja Sathe, et al.. (2021). Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma. Blood. 137(21). 2869–2880. 48 indexed citations

Mooney, Kelly L., Debra K. Czerwinski, Tanaya Shree, et al.. (2021). Serial FNA allows direct sampling of malignant and infiltrating immune cells in patients with B‐cell lymphoma receiving immunotherapy. Cancer Cytopathology. 130(3). 231–237. 2 indexed citations

10.

Shree, Tanaya, Michael S. Khodadoust, Debra K. Czerwinski, et al.. (2020). Intratumoral CpG, Local Radiation, and Oral Ibrutinib Combine to Produce Effective in Situ Vaccination in Patients with Low-Grade B-Cell Lymphoma. Blood. 136(Supplement 1). 48–48. 3 indexed citations

11.

Shree, Tanaya, Michael S. Khodadoust, Debra K. Czerwinski, et al.. (2019). A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma. Blood. 134(Supplement_1). 2825–2825. 2 indexed citations

12.

Haebe, Sarah, Tanaya Shree, Anuja Sathe, et al.. (2019). Site to Site Comparison of Follicular Lymphoma Biopsies By Single Cell RNA Sequencing. Blood. 134(Supplement_1). 297–297. 4 indexed citations

13.

Czerwinski, Debra K., et al.. (2018). In Situ Vaccination with Cpg and Anti-OX40 Antibody: Preclinical Optimization for Clinical Translation. Blood. 132(Supplement 1). 2943–2943. 3 indexed citations

14.

Shree, Tanaya, Qian Li, Sally L. Glaser, et al.. (2017). Increased Incidence of Autoimmune and Infectious Diseases Among a Large Group of Diffuse Large B-Cell Lymphoma (DLBCL) Survivors: A Population-Based Study. Blood. 130. 198–198. 1 indexed citations

15.

Shree, Tanaya, Oakley C. Olson, Benelita T. Elie, et al.. (2011). Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. Genes & Development. 25(23). 2465–2479. 438 indexed citations

16.

Gocheva, Vasilena, Hao‐Wei Wang, Bedrick B. Gadea, et al.. (2010). IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes & Development. 24(3). 241–255. 577 indexed citations breakdown →

17.

Elie, Benelita T., Vasilena Gocheva, Tanaya Shree, et al.. (2010). Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model. Biochimie. 92(11). 1618–1624. 50 indexed citations

18.

Gocheva, Vasilena, Haowei Wang, Bedrick B. Gadea, et al.. (2010). Abstract LB-379: IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Cancer Research. 70(8_Supplement). LB–379. 1 indexed citations

19.

Hayley, Shawn, Stephen J. Crocker, Patrice D. Smith, et al.. (2004). Regulation of Dopaminergic Loss by Fas in a 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease. Journal of Neuroscience. 24(8). 2045–2053. 98 indexed citations

20.

Ghahremani, Mohammad H., Elizabeth Keramaris, Tanaya Shree, et al.. (2002). Interaction of the c-Jun/JNK Pathway and Cyclin-dependent Kinases in Death of Embryonic Cortical Neurons Evoked by DNA Damage. Journal of Biological Chemistry. 277(38). 35586–35596. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact